Benzinga | Aug 30, 2021 06:19AM EDT

HC Wainwright & Co. Maintains Buy on Aadi Biosciences, Inc. - Common Stock, Raises Price Target to $47

HC Wainwright & Co. analyst Robert Burns maintains Aadi Biosciences, Inc. - Common Stock (NASDAQ:AADI) with a Buy and raises the price target from $22 to $47.